• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

    198.64 -1.32 (-0.66%)
    Streaming Delayed Price Updated: 10:32 AM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 47,224
    Open 200.24
    Bid (Size) 196.71 (100)
    Ask (Size) 200.21 (100)
    Prev. Close 199.96
    Today's Range 197.04 - 204.86
    52wk Range 93.58 - 212.49
    Shares Outstanding 16,676,532
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗
    Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based model. 
    Via Investor's Business Daily
    News headline image
    This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know ↗
    A high-conviction fund just trimmed one of its biggest winners—here’s what long-term investors should make of the move. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +4.5%
    +4.5%
    1 Month
    +7.6%
    +7.6%
    3 Month
    +7.7%
    +7.7%
    6 Month
    +62.3%
    +62.3%
    1 Year
    +80.1%
    +80.1%

    More News

    Read More
    News headline image
    Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter ↗
    Via The Motley Fool
    News headline image
    This Fund Cut $7.3 Million of Atlas Energy Stock as the Company Suspends Its Dividend to Help Fuel Growth ↗
    Via The Motley Fool
    Topics Economy Regulatory Compliance
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 8, 2025 ↗
    Via Benzinga
    News headline image
    Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch ↗
    Via Benzinga
    News headline image
    Ligand (LGND) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Ligand Pharmaceuticals (NASDAQ:LGND) Surges on Strong Q3 2025 Earnings Beat and Raised Guidance ↗
    Via Chartmill
    Topics Earnings
    News headline image
    What's Next: Ligand Pharmaceuticals's Earnings Preview ↗
    Via Benzinga
    News headline image
    Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    News headline image
    What Analysts Are Saying About Ligand Pharmaceuticals Stock ↗
    Via Benzinga
    News headline image
    Ligand (LGND) Q2 Revenue Jumps 15% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Ligand Pharmaceuticals (NASDAQ:LGND) Surpasses Q2 2025 Earnings Estimates with Strong Royalty Growth ↗
    Via Chartmill
    News headline image
    Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Pelthos, Ligand Gain After Launch Of First Prescription-At-Home Treatment For Water Warts ↗
    Via Stocktwits
    Topics Government
    News headline image
    Pelthos Therapeutics Launches First At-Home Prescription Gel For Highly Contagious Skin Disease ↗
    Via Benzinga
    News headline image
    Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗
    Via Benzinga
    News headline image
    Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings ↗
    Via Benzinga
    News headline image
    Channel Therapeutics Stock Soars On Announcement Of Subsidiary’s Merger With Ligand Pharma Units: Retail’s Elated ↗
    Via Stocktwits
    News headline image
    Dow Falls Over 1%; US Initial Jobless Claims Decline ↗
    Via Benzinga
    Topics Stocks
    News headline image
    EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity ↗
    Via Benzinga

    Frequently Asked Questions

    Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?
    Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.
    What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?
    Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?
    The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market
    What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?
    The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 198.64
    When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?
    The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 01/08/26 10:32 AM ET
    What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?
    The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 3.31B
    How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?
    Ligand Pharmaceuticals Incorporated - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.